Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.35
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $170.84 million as of December 5, 2025. Its market cap has decreased by -2.38% in one year.
Market Cap
170.84M
Enterprise Value
153.91M
1-Year Change
-2.38%
Ranking
Category
Stock Price
$7.35
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $170.84M, an increase of 12.30%. That is a compound annual growth rate of 9.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 170.84M | 9.88% |
| Dec 31, 2024 | 155.47M | 2.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |